NCT01624194View on ClinicalTrials.gov

Intranasal Oxytocin Treatment for Social Deficits in Children With Autism

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Autism
Interventions
DRUG

Oxytocin nasal spray

24IU BID (3 x 0.1 mL \[4IU\] sprays per nostril twice daily for 4-weeks.

DRUG

Placebo

3 x 0.1 mL sprays per nostril twice daily for 4-weeks.

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT01624194 - Intranasal Oxytocin Treatment for Social Deficits in Children With Autism | Biotech Hunter | Biotech Hunter